Skip to main content
Log in

Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists

  • Original Article
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Summary

The purpose of this study was to examine the effect of three classes of Ca2+ antagonists, diltiazem, verapamil and nifedipine on Na+-Ca2+ exchange mechanism in the sarcolemmal vesicles isolated from canine heart. Na+-Ca2+ exchange and Ca2+ pump (ATP-dependent Ca2+ uptake) activities were assessed using the Millipore filtration technique. sarcolemmal vesicles used in this study are estimated to consist of several subpopulations wherein 23% are inside-out and 55% are right side-out sealed vesicles in orientation. The affect of each Ca2+ antagonist on the Na+-dependent Ca2+ uptake was studied in the total population of sarcolemmal vesicles, in which none of the agents depressed the initial rate of Ca2+ uptake until concentrations of 10 μM were incubated in the incubation medium. However, when sarcolemmal vesicles were preloaded with Ca2+ via ATP-dependent Ca2+ uptake, cellular Ca2+ influx was depressed only by verapamil (28%) at 1 μM in the efflux medium with 8 mM Na+. Furthermore, inhibition of Ca2+ efflux by verapamil was more pronounced in the presence of 16 mM Na+ in the efflux medium. The order of inhibition was; verapamil > diltiazem > nifedipine. These results indicate that same forms of Ca2+-antagonist drugs may affect the Na+-Ca2+ exchange mechanism in the cardiac sarcolemmal vesicles and therefore we suggest this site of action may contribute to their effects on the myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reuter H: Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301:569–573, 1983

    Google Scholar 

  2. Glossman H, Ferry DR, Coll A, Rombush M: Molecular pharmacology of the calcium channel: Evidence for subtypes, multiple drug-receptor sites, channel subunits, and development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.J Cardiovasc Pharmacol 6(suppl 4): S608–5621, 1984

    Google Scholar 

  3. Schwartz A, Taira N: Calcium channel-blocking drugs: a novel intervention for the treatment of cardiac disease. Circ Res 52 (suppl II): I1-I2, 1983

    Google Scholar 

  4. Bolger G, Gengo P, Klockowski R, Luchowski E, Siegel H, Janis RA, Triggle AM: Characterization of binding of the Ca2+-channel antagonist, [3H]nitrendipine, to guinea pig ileal smooth muscle. J Pharmacol Exp Ther 225:291–309, 1983

    Google Scholar 

  5. Glossman H, Ferry DR, Goll A, Strissnig J and Schober M: Calcium channels:basic properties as revealed by radioligand binding tudies. J Cardiovasc Pharmacol 7 (suppl 6):S20-S30, 1985

    Google Scholar 

  6. Carcia ML, Frank King V, Siegel PKS, Reuban JP and Kazorowski GJ: Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. J Biol Chem 261:8146–8157, 1986

    Google Scholar 

  7. Bostrom SL, Ljung B, Mardh S, Forsen S and Thulin E: Interaction of the antihypertensive drug felodipine with calmodulin. Nature 292:777–778, 1981

    Google Scholar 

  8. Pang DC, Sperelakis N: Nifedipine, diltiazem, bepridil and verapamil uptake into cardiac and smooth muscles. Eur J Pharmacol 87:199–207, 1983

    Google Scholar 

  9. Cramb G, Dow JW: Uptake of bepridil into isolated ventricular myocytes; Retention by actin. Biochem Pharmacol 32:227–231, 1983

    Google Scholar 

  10. Norman JA, Ansell J, Phillips MA: Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase. Eur J Pharmacol 93:107–112, 1983

    Google Scholar 

  11. Mas-Oliver J, Nayler WG: The effect of verapamil on Ca2+-transporting and Ca2+-ATPase activity of isolated cardiac sarcolemmal preparations. Br J Pharmacol 70:617–624, 1980

    Google Scholar 

  12. Reuter H: Exchange of calcium ions in the mammalian myocardium. Mechanism and physiological significance. Circ Res 34:599–605, 1974

    Google Scholar 

  13. Caroni P, Carafoli E: The Ca2+-pumping ATPase of heart sarcolemma. J Biol Chem 256:3263–3270, 1987

    Google Scholar 

  14. Phillipson KD, Nishimoto AY: Stimulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by proteinase pretreatment. Am J Physiol 243:C191-C195, 1982

    Google Scholar 

  15. Phillipson KD, Nishimoto AY: Stimulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by phospholipase D. J Biol Chem 259:16–19, 1984

    Google Scholar 

  16. Phillipson KD: Interaction of charged amphiphils with Na+-Ca2+ exchange in cardiac sarcolemmal vesicles. J Biol Chem 259:13999–14002, 1984

    Google Scholar 

  17. Phillipson KD, Bersohn MM, Nishimoto AY: Effect of pH on Na2+-Ca2+ exchange in canine cardiac sarcolemmal vesicles. Circ Res 50:287–293, 1982

    Google Scholar 

  18. Reeves JP, Bailey CA, Hale CC: Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem 261:4948–4955, 1986

    Google Scholar 

  19. Van Amsterdam FTM and Zaagsma J: Modulation of ATP dependent Ca2+ extrusion and Na+/Ca2+ exchange acrose rat cardiac sarcolemma by calcium antagonists. Eur J Pharmacol 123:441–449, 1986

    Google Scholar 

  20. Takeo S, Elimban V, Dhalla NS: Modification of cardiac sarcolemmal Na+-Ca2+ exchange by diltiazem and verapamil. Can J Cardiol 1:131–138, 1985

    Google Scholar 

  21. David-Dufilho M, Aude DeVynck M, Kazda S, Meyer M: Stimulation by nifedipine of calcium transport by cardiac sarcolemmal vesicles from spontaneously hypertensive rats. Eur J Pharmacol 97:121–127, 1984

    Google Scholar 

  22. Pitts BJR: Stoichiometry of sodium-calcium exchange in cardia sarcolemmal vesicles. J Biol Chem 254:6232–6235, 1979

    Google Scholar 

  23. Lowry OH, Resenbrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193:265–275, 1951

    CAS  PubMed  Google Scholar 

  24. Taussky HH, Shorr E: A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202:675–685, 1953

    PubMed  Google Scholar 

  25. Lamers JM, Stinis JT, Kort WJ, Hullsman WG: Biochemical studies on the sarcolemmal function in the hypertrophied rabbit heart. J Mol Cell Cardiol 10:235–248, 1978

    Google Scholar 

  26. Masters BSS, William Jr CH, Kamin H: The preparation and properties of microsomal TPNH-cytochrome C reductase from pig liver. In: Estabrook RW, Pullmann ME (eds) Method in Enzymology. New York Academic Press 1967: 10 pp 565–573

  27. Wharton DC, Tzagoloff A: Cytochrome oxidase from beef heart mitochrondria. In: Estabrook RE, Pullmann ME (eds) Method in Enzymology. New York Academic Press 1967: 10 pp 245–250

  28. Makino N, Dhurubarajan R, Elimban V, Beamish RE, Dhalla NS: Alteration of sarcolemmal Na+-Ca2+ exchange in catecholamine-induced cardiomyopathy. Can J Cardiol 1:225–232, 1985

    Google Scholar 

  29. Makino N, Jasmin G, Beamish RE, Dhalla NS: Sarcolemmal Na+-Ca2+ exchange during the development of genetically determined cardiomyopathy. Biochem Biophys Res Commun 133:491–497, 1985

    Google Scholar 

  30. Panagia V, Makino N, Gangly P, Dhalla NS: Inhibition of Na+-Ca2+ exchange in heart sarcolemmal vesicles by phosphatidylethanolamine N-methylation. Eur J Biochem 166:597–603, 1987

    Google Scholar 

  31. Makino N, Dhalla KS, Elimban V, Dhalla NS: Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy. Am J Physiol 253:E202-E207, 1987

    Google Scholar 

  32. Lucian S: Reconstitution of the sodium-calcium exchanger from cardiac sarcolemmal vesicles. Biochem Biophy Acta 772:127–134, 1984

    Google Scholar 

  33. Caroni P, Carafoli E: The regulation of the Na+-Ca2+ exchange of heart sarcolemma. Eur J Biochem 132:451–460, 1983

    Google Scholar 

  34. Bers DM, Allen LH, Kim Y: Calcium binding to cardiac sarcolemmal vesicles: potential role as a modifier of contraction. Am J Physiol 251:C861-C871, 1986

    Google Scholar 

  35. Phillipson KD: Symmetry properties of the Na+-Ca2+ exchange mechanisms in cardiac sarcolemmal vesicles. Biochem Biophy Acta 821:367–376, 1985

    Google Scholar 

  36. Lamers JM, Gysouw KJ, Verdouw PD: Slow calcium channel blockers and calmodulin. Biochem Pharmacol 34:3837–3843, 1985

    Google Scholar 

  37. Erdreich A, Spanier R, Rahamimoff H: The inhibition of Na+-dependent Ca2+ uptake by verapamil in synaptic plasma membrane vesicles. Eur J Pharmacol 90:193–202, 1983

    Google Scholar 

  38. Vaghy PL, Johnson JD, Matlib MA, Wang T, Schwartz A: Selective inhibition of Na+-induced Ca2+ release from heart mitochondria by diltiazem and certain other Ca2+-antagonist drugs. J Biol Chem 257:6000–6002, 1982

    Google Scholar 

  39. Younes A, Constantin M: Effects of bepridil on mitochondrial ATPase reactions. Biochem Pharmacol 29:1135–1139, 1980

    Google Scholar 

  40. Colvin RA, Pearson N, Messineo FC, Katz AM: Effect of Ca2+-channel blockers on Ca2+ transport and Ca2+ ATPase in skeletal and cardiac sarcoplasmic reticulum vesicles. J Cardiovasc Pharmacol 4:935–941, 1982

    Google Scholar 

  41. Itoh H, Ishikawa T, Hidaka H: Effects on calmodulin of bepridil, an antianginal agents. J Pharmacol Exp Ther 230:737–741, 1984

    Google Scholar 

  42. Agre PD, Virshup D, Bennet V: Bepridil and cetiedil, vasodilator which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes. J Clin Invest 74:812–820, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hata, T., Makino, N., Nakanishi, H. et al. Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists. Mol Cell Biochem 84, 65–76 (1988). https://doi.org/10.1007/BF00235194

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00235194

Key words

Navigation